Abstract
The paper deals with the evolution of R&D networks in the biopharmaceutical industries. For this purpose, an agent-based-computational model towards evolutionary economics is developed which is able to generate results which closely correspond to developments in the real world. With this approach, the permanent nature of R&D networks in the industrial organisation of innovation processes in this increasingly important industry as well as the coexistence of large diversified firms and dedicated biotechnology firms, can be explained.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Entrepreneurship and Innovation Management
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
